Skip to main content

Fresenius Medical Care Value Stock - Dividend - Research Selection

Fresenius Medical Care AG & Co. KGaA

ISIN: DE0005785802, WKN: 578580

Market price date: 16.05.2022
Market price: 56,56 EUR


Fresenius Medical Care AG & Co. KGaA Fundamental data and company key figures of the share

Annual reports in EUR
Key figures 16-03-2022
Cash flow
Net operating cash flow 2.489.500.000
Capital Expenditures -854.360.000
Free cash flow 1.635.139.968
Balance sheet
Total Equity 13.979.000.000
Liabilities & Shareholders equity 34.367.000.000
Income statement
Net income 969.000.000
Eps (diluted) 3,310
Diluted shares outstanding 293.004.000
Net sales/revenue 17.619.000.000

Fundamental ratios calculated on: 16-05-2022

Ratios
Key figures 16-05-2022
Cash flow
P/C 6,66
   
P/FC 10,14
Balance sheet
ROI2,82
ROE40,68
Income statement
P/E17,09
Div. Yield2,39%
P/B1,19
P/S0,94


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolFME.F
Market Capitalization20.099.825.664,00 USD
CountryGermany
IndicesCDAX,Dax,HDAX,MSCI World Index,STOXX EUROPE 600
SectorsHealth Care Services
Raw Data SourceIFRS in Millionen EUR
Stock Split2007-06-18,3.0000/1.0000
Internetwww.freseniusmedicalcare.com


Description of the company

Fresenius Medical Care AG & Co KGaA is a Germany-based holding and kidney dialysis company, operating in the fields of dialysis products and dialysis services. Its dialysis business is vertically integrated, providing dialysis treatment at its own dialysis clinics and supplying these clinics with a range of products. In addition, the Company sells dialysis products to other dialysis service providers. The Company operates in two business segments: North America and International. The North America segment consists of Renal Therapy Group and Fresenius Medical Services. The International segment consists of Europe and Latin America and one Asia-Pacific unit. During the year ended December 31, 2010, the Company's subsidiary, U.S. Vascular Access Holdings, LLC, completed the acquisition of National Vascular Care Inc.; it acquired a total of 168 existing clinics, and acquired Gambro AB's peritoneal dialysis (PD) business. The Company has a total of 1000 subsidiaries worldwide

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.freseniusmedicalcare.com


NEWS